Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma

This post was originally published on this site

Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma.